AstraZeneca

European stocks closed marginally lower yesterday as energy shares gave up a chunk of Monday’s big gains and banks lost steam ahead of likely interest(...)

Irish shares rose on Monday, a day on which volume was thin due to a US market holiday, Labour Day. Elsewhere, London’s FTSE 100 surged 1 per cent on(...)

Irish stocks outperformed European peers yesterday as markets globally rallied on hopes of a resolution to a trade dispute between the US and China. (...)

Global stocks advanced on Wednesday as investors await minutes from the US Federal Reserve’s July meeting for signs of future rate cuts. Dublin outper(...)

A combination of AstraZeneca’s lung cancer drug Imfinzi and an experimental treatment failed to extend the lives of patients with advanced non-small c(...)

European stocks ground out a tiny gain on Monday, as a pair of big merger reports and a weak pound sent London’s FTSE 100 higher, while defensive play(...)

Markets fell as the European Central Bank disappointed those hoping for firm news of an interest rate cut on Thursday, although the bank did signal th(...)

UK pharmaceutical company GlaxoSmithKline is poised to name Jonathan Symonds, a former executive at rivals AstraZeneca and Novartis, as its next chair(...)

Markets ended the week on a cautious note, with European shares a mixed bag and the FTSE notching up its seventh day in the red. Disappointing data f(...)

Weak German economic data and a profit warning from Daimler hit European stock markets on Monday as investors reined in any bets on a fourth week of g(...)